Page last updated: 2024-11-08

pomolic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

pomolic acid: from Rosa woodsii & Hyptis capitata; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

FloraRankFlora DefinitionFamilyFamily Definition
RosagenusA plant genus in the family ROSACEAE and order Rosales. This should not be confused with the genus RHODIOLA which is sometimes called roseroot.[MeSH]RosaceaeThe rose plant family in the order ROSALES and class Magnoliopsida. They are generally woody plants. A number of the species of this family contain cyanogenic compounds.[MeSH]
Rosa woodsiispecies[no description available]RosaceaeThe rose plant family in the order ROSALES and class Magnoliopsida. They are generally woody plants. A number of the species of this family contain cyanogenic compounds.[MeSH]
Rosa woodsiispecies[no description available]RosaceaeThe rose plant family in the order ROSALES and class Magnoliopsida. They are generally woody plants. A number of the species of this family contain cyanogenic compounds.[MeSH]
Rosa woodsiispecies[no description available]RosaceaeThe rose plant family in the order ROSALES and class Magnoliopsida. They are generally woody plants. A number of the species of this family contain cyanogenic compounds.[MeSH]

Cross-References

ID SourceID
PubMed CID382831
CHEMBL ID486986
CHEBI ID66772
SCHEMBL ID1049001
MeSH IDM0297461

Synonyms (32)

Synonym
NCI60_024874
nsc670661
nsc-670661
urs-12-en-28-oic acid, 3,19-dihydroxy-, (3.beta.)-
13849-91-7
pomolic acid
(1r,2r,4as,6ar,6as,6br,8ar,10s,12ar,14bs)-1,10-dihydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid
bdbm50241553
chebi:66772 ,
CHEMBL486986 ,
1,10-dihydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid
60hab1zk1t ,
urs-12-en-28-oic acid, 3,19-dihydroxy-, (3beta)-
unii-60hab1zk1t
S9562
19.alpha.-hydroxyursolic acid
benthamic acid
urs-12-en-28-oic acid, 3.beta.,19-dihydroxy-
randialic acid a
3.beta.,19.alpha.-dihydroxy urs-12-en-28-oic acid
SCHEMBL1049001
19alpha-hydroxyursolic acid
urs-12-en-28-oic acid, 3beta,19-dihydroxy-
3beta,19alpha-dihydroxy urs-12-en-28-oic acid
AKOS032948112
Q27135401
DTXSID20930133
3,19-dihydroxyurs-12-en-28-oic acid
CS-0034332
MS-28755
HY-N6601
E80683

Research Excerpts

Overview

Pomolic acid (PA) is a pentacyclic triterpene which has been previously described as active in inhibiting the growth of K562 cell line-originated from chronic myeloid leukemia.

ExcerptReferenceRelevance
"Pomolic acid (PA) is a pentacyclic triterpene which has been previously described as active in inhibiting the growth of K562 cell line-originated from chronic myeloid leukemia (CML) in blast crisis-and its vincristine-resistant derivative K562-Lucena1. "( Pomolic acid-induced apoptosis in cells from patients with chronic myeloid leukemia exhibiting different drug resistance profile.
Gattass, CR; Maia, RC; Rumjanek, VM; Vasconcelos, FC, 2007
)
3.23

Effects

Pomolic acid (PA) has been previously described as being active in inhibiting the growth of cancer cells. Pomolic acid has recently shown hypotensive effect in rats.

ExcerptReferenceRelevance
"Pomolic acid has recently shown hypotensive effect in rats. "( Pomolic acid of Licania pittieri elicits endothelium-dependent relaxation in rat aortic rings.
Alvarado-Castillo, C; Cardozo, A; Estrada, O; Fernández, AZ; González-Guzmán, JM; Salazar-Bookaman, M, 2011
)
3.25
"Pomolic acid (PA) has been previously described as being active in inhibiting the growth of cancer cells."( Anticancer properties of pomolic acid-induced AMP-activated protein kinase activation in MCF7 human breast cancer cells.
Cha, EY; Chang, ES; Kim, JR; Lee, JS; Lee, MS; Thuong, PT; Youn, SH, 2012
)
1.4

Treatment

ExcerptReferenceRelevance
"Pomolic acid‑treated cells exhibited red fluorescence, and the intensity of this fluorescence increased in a dose‑dependent manner, indicating apoptosis induction."( Antitumor‑ and apoptosis‑inducing effects of pomolic acid against SK‑MEL‑2 human malignant melanoma cells are mediated via inhibition of cell migration and sub‑G1 cell cycle arrest.
Li, TH; Yan, HX, 2018
)
1.46
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
metaboliteAny intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
triterpenoidAny terpenoid derived from a triterpene. The term includes compounds in which the C30 skeleton of the parent triterpene has been rearranged or modified by the removal of one or more skeletal atoms (generally methyl groups).
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (2)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Tyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)IC50 (µMol)3.90000.00053.49849.7600AID391031
Sentrin-specific protease 1Homo sapiens (human)IC50 (µMol)5.10000.00642.64466.1000AID1868240
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (34)

Processvia Protein(s)Taxonomy
positive regulation of JUN kinase activityTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
protein dephosphorylationTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
insulin receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
regulation of signal transductionTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
negative regulation of signal transductionTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
actin cytoskeleton organizationTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
regulation of endocytosisTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
negative regulation of vascular endothelial growth factor receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
endoplasmic reticulum unfolded protein responseTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
regulation of intracellular protein transportTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
cellular response to unfolded proteinTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
peptidyl-tyrosine dephosphorylationTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
platelet-derived growth factor receptor-beta signaling pathwayTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
IRE1-mediated unfolded protein responseTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
insulin receptor recyclingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
negative regulation of MAP kinase activityTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
negative regulation of insulin receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
regulation of type I interferon-mediated signaling pathwayTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
growth hormone receptor signaling pathway via JAK-STATTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
positive regulation of protein tyrosine kinase activityTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
negative regulation of ERK1 and ERK2 cascadeTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
regulation of hepatocyte growth factor receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathwayTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
positive regulation of IRE1-mediated unfolded protein responseTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
negative regulation of PERK-mediated unfolded protein responseTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activityTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
positive regulation of receptor catabolic processTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
positive regulation of transcription by RNA polymerase IISentrin-specific protease 1Homo sapiens (human)
proteolysisSentrin-specific protease 1Homo sapiens (human)
activation of cysteine-type endopeptidase activity involved in apoptotic processSentrin-specific protease 1Homo sapiens (human)
protein sumoylationSentrin-specific protease 1Homo sapiens (human)
protein desumoylationSentrin-specific protease 1Homo sapiens (human)
regulation of mRNA stabilitySentrin-specific protease 1Homo sapiens (human)
apoptotic signaling pathwaySentrin-specific protease 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (15)

Processvia Protein(s)Taxonomy
RNA bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
protein tyrosine phosphatase activityTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
insulin receptor bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
protein bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
zinc ion bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
enzyme bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
protein kinase bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
receptor tyrosine kinase bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
cadherin bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
ephrin receptor bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
protein phosphatase 2A bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
non-membrane spanning protein tyrosine phosphatase activityTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
endopeptidase activitySentrin-specific protease 1Homo sapiens (human)
protein bindingSentrin-specific protease 1Homo sapiens (human)
deSUMOylase activitySentrin-specific protease 1Homo sapiens (human)
SUMO-specific endopeptidase activitySentrin-specific protease 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (15)

Processvia Protein(s)Taxonomy
plasma membraneTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
cytoplasmTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
mitochondrial matrixTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
early endosomeTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
endoplasmic reticulumTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
cytosolTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
mitochondrial cristaTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
endosome lumenTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
sorting endosomeTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
cytoplasmic side of endoplasmic reticulum membraneTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
protein-containing complexTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
endoplasmic reticulumTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
cytoplasmTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
early endosomeTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
nucleoplasmSentrin-specific protease 1Homo sapiens (human)
cytoplasmSentrin-specific protease 1Homo sapiens (human)
focal adhesionSentrin-specific protease 1Homo sapiens (human)
nuclear membraneSentrin-specific protease 1Homo sapiens (human)
nucleusSentrin-specific protease 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (43)

Assay IDTitleYearJournalArticle
AID426216Cytotoxicity against human SKOV3 cells upto 50 uM by neutral red assay2009Journal of natural products, Jun, Volume: 72, Issue:6
Scuteflorins A and B, dihydropyranocoumarins from Scutellaria lateriflora.
AID426207Cytotoxicity against african green monkey Vero cells upto 50 uM by neutral red assay2009Journal of natural products, Jun, Volume: 72, Issue:6
Scuteflorins A and B, dihydropyranocoumarins from Scutellaria lateriflora.
AID1868241Inhibition of SENP1 in human SK-OV-3 cells assessed as increase in SUMOlytated JAK2 level at 5 uM after 48 hrs by immunoprecipitation method2022Journal of natural products, 05-27, Volume: 85, Issue:5
Discovery of Natural Ursane-type SENP1 Inhibitors and the Platinum Resistance Reversal Activity Against Human Ovarian Cancer Cells: A Structure-Activity Relationship Study.
AID1868239Inhibition of recombinant human SENP1 assessed as reduction in deSUMOylation of RanGAP1-SUMO1 at 5 uM using RanGAP1-SUMO1 as substrate preincubated for 10 mins followed by substrate addition and measured after 30 mins relative to control2022Journal of natural products, 05-27, Volume: 85, Issue:5
Discovery of Natural Ursane-type SENP1 Inhibitors and the Platinum Resistance Reversal Activity Against Human Ovarian Cancer Cells: A Structure-Activity Relationship Study.
AID1446873Inhibition of wild-type HIV1 RT associated RNA dependent DNA polymerase activity using poly(A) template/oligo(dT) primer after 30 mins by picogreen staining based method2017European journal of medicinal chemistry, Apr-21, Volume: 130Natural product-inspired esters and amides of ferulic and caffeic acid as dual inhibitors of HIV-1 reverse transcriptase.
AID426212Cytotoxicity against human HepG2 cells upto 50 uM by neutral red assay2009Journal of natural products, Jun, Volume: 72, Issue:6
Scuteflorins A and B, dihydropyranocoumarins from Scutellaria lateriflora.
AID527184Cytotoxicity against human CEM cells at 10 uM after 48 hrs2010Journal of natural products, Oct-22, Volume: 73, Issue:10
Cytotoxic Hexacyclic Triterpene Acids from Euscaphis japonica.
AID1868245Reversal of platinum resistance in cisplatin-resistant human SK-OV-3 cells assessed as reduction in cisplatin IC50 after 48 hrs in presence of cisplatin by SRB assay (Rvb = 28.23 microM)2022Journal of natural products, 05-27, Volume: 85, Issue:5
Discovery of Natural Ursane-type SENP1 Inhibitors and the Platinum Resistance Reversal Activity Against Human Ovarian Cancer Cells: A Structure-Activity Relationship Study.
AID402092Cytotoxicity against mock-infected human H9 cells after 4 days1998Journal of natural products, Sep, Volume: 61, Issue:9
Anti-AIDS agents. 30. Anti-HIV activity of oleanolic acid, pomolic acid, and structurally related triterpenoids.
AID378287Cytotoxicity against mock-infected human H9 cells2000Journal of natural products, Dec, Volume: 63, Issue:12
Anti-AIDS agents 38. Anti-HIV activity of 3-O-acyl ursolic acid derivatives.
AID1868244Cytotoxicity against human SK-OV-3 cells assessed as cell viability at 500 uM incubated for 48 hrs by SRB assay2022Journal of natural products, 05-27, Volume: 85, Issue:5
Discovery of Natural Ursane-type SENP1 Inhibitors and the Platinum Resistance Reversal Activity Against Human Ovarian Cancer Cells: A Structure-Activity Relationship Study.
AID402093Therapeutic index, ratio of IC50 for human H9 cells to EC50 for HIV1 3B1998Journal of natural products, Sep, Volume: 61, Issue:9
Anti-AIDS agents. 30. Anti-HIV activity of oleanolic acid, pomolic acid, and structurally related triterpenoids.
AID464582Cytotoxicity against human HCT15 cells by SRB assay2010Bioorganic & medicinal chemistry letters, Mar-15, Volume: 20, Issue:6
Bioactivity-guided isolation of cytotoxic triterpenoids from the trunk of Berberis koreana.
AID1868240Inhibition of recombinant human SENP1 assessed as reduction in deSUMOylation using RanGAP1-SUMO1 as substrate preincubated for 10 mins followed by substrate addition and measured after 30 mins2022Journal of natural products, 05-27, Volume: 85, Issue:5
Discovery of Natural Ursane-type SENP1 Inhibitors and the Platinum Resistance Reversal Activity Against Human Ovarian Cancer Cells: A Structure-Activity Relationship Study.
AID1446872Inhibition of recombinant HIV-1 group M subtype B RT-RNase H activity expressed in Escherichia coli M15 using 18-nucleotide 3'-fluorescein-labeled RNA annealed to a complementary 18-nucleotide 5'-dabsyl-labeled DNA as substrate measured after 1 hr2017European journal of medicinal chemistry, Apr-21, Volume: 130Natural product-inspired esters and amides of ferulic and caffeic acid as dual inhibitors of HIV-1 reverse transcriptase.
AID1615642Bactericidal activity against Haemophilus influenzae type b ATCC 49247 incubated for 24 hrs followed by transferring to freshly prepared broth medium and measured after 24 hrs by M7-A9 microdilution method2019Journal of natural products, 09-27, Volume: 82, Issue:9
Constituents from
AID426208Cytotoxicity against pig LLC-PK11 cells upto 50 uM by neutral red assay2009Journal of natural products, Jun, Volume: 72, Issue:6
Scuteflorins A and B, dihydropyranocoumarins from Scutellaria lateriflora.
AID426214Cytotoxicity against human KB cells upto 50 uM by neutral red assay2009Journal of natural products, Jun, Volume: 72, Issue:6
Scuteflorins A and B, dihydropyranocoumarins from Scutellaria lateriflora.
AID1615641Antibacterial activity against Haemophilus influenzae type b ATCC 49247 incubated for 24 hrs by M7-A9 microdilution method2019Journal of natural products, 09-27, Volume: 82, Issue:9
Constituents from
AID1868242Cytotoxicity against human SK-OV-3 cells assessed as reduction in cell viability at 25 uM incubated for 48 hrs by SRB assay2022Journal of natural products, 05-27, Volume: 85, Issue:5
Discovery of Natural Ursane-type SENP1 Inhibitors and the Platinum Resistance Reversal Activity Against Human Ovarian Cancer Cells: A Structure-Activity Relationship Study.
AID527185Cytotoxicity against human fibroblast cells at 10 uM after 48 hrs2010Journal of natural products, Oct-22, Volume: 73, Issue:10
Cytotoxic Hexacyclic Triterpene Acids from Euscaphis japonica.
AID426211Inhibition of SP1-dependent luciferase expression2009Journal of natural products, Jun, Volume: 72, Issue:6
Scuteflorins A and B, dihydropyranocoumarins from Scutellaria lateriflora.
AID1436763Anticomplement activity in sheep erythrocytes assessed as concentration required for 50% hemolytic inhibition by classic pathway preincubated for 10 mins with guinea pig serum followed by erythrocyte addition measured after 30 mins by spectrophotometer2017Bioorganic & medicinal chemistry letters, 02-15, Volume: 27, Issue:4
Anticomplement triterpenoids from the roots of Ilex asprella.
AID527181Cytotoxicity against human MCF7 cells at 10 uM after 48 hrs2010Journal of natural products, Oct-22, Volume: 73, Issue:10
Cytotoxic Hexacyclic Triterpene Acids from Euscaphis japonica.
AID527183Cytotoxicity against human HT-29 cells at 10 uM after 48 hrs2010Journal of natural products, Oct-22, Volume: 73, Issue:10
Cytotoxic Hexacyclic Triterpene Acids from Euscaphis japonica.
AID402091Antiviral activity against HIV1 3B in human H9 cells after 4 days by p24 antigen ELISA1998Journal of natural products, Sep, Volume: 61, Issue:9
Anti-AIDS agents. 30. Anti-HIV activity of oleanolic acid, pomolic acid, and structurally related triterpenoids.
AID1868246Synergistic reversal of platinum resistance in cisplatin-resistant human SK-OV-3 cells assessed as combination index after 48 hrs in presence of cisplatin by SRB assay2022Journal of natural products, 05-27, Volume: 85, Issue:5
Discovery of Natural Ursane-type SENP1 Inhibitors and the Platinum Resistance Reversal Activity Against Human Ovarian Cancer Cells: A Structure-Activity Relationship Study.
AID378286Antiviral activity against HIV1 3B isolate replication in human H9 cells assessed as decrease in viral p24 level after 4 days2000Journal of natural products, Dec, Volume: 63, Issue:12
Anti-AIDS agents 38. Anti-HIV activity of 3-O-acyl ursolic acid derivatives.
AID391031Inhibition of human recombinant PTP1B after 30 mins2008Journal of natural products, Oct, Volume: 71, Issue:10
Triterpenoids from the leaves of Diospyros kaki (persimmon) and their inhibitory effects on protein tyrosine phosphatase 1B.
AID1439501Nematocidal activity against Meloidogyne incognita2017European journal of medicinal chemistry, Mar-31, Volume: 129Medicinal plants used as anthelmintics: Ethnomedical, pharmacological, and phytochemical studies.
AID378288Therapeutic index, IC50 for human T-lymphoid H9 cells to EC50 for HIV1 3B isolate2000Journal of natural products, Dec, Volume: 63, Issue:12
Anti-AIDS agents 38. Anti-HIV activity of 3-O-acyl ursolic acid derivatives.
AID1868243Cytotoxicity against human SK-OV-3 cells assessed as reduction in cell viability incubated for 48 hrs by SRB assay2022Journal of natural products, 05-27, Volume: 85, Issue:5
Discovery of Natural Ursane-type SENP1 Inhibitors and the Platinum Resistance Reversal Activity Against Human Ovarian Cancer Cells: A Structure-Activity Relationship Study.
AID426210Cytotoxicity against human SW1353 cells by neutral red assay2009Journal of natural products, Jun, Volume: 72, Issue:6
Scuteflorins A and B, dihydropyranocoumarins from Scutellaria lateriflora.
AID527182Cytotoxicity against human NCI-H460 cells at 10 uM after 48 hrs2010Journal of natural products, Oct-22, Volume: 73, Issue:10
Cytotoxic Hexacyclic Triterpene Acids from Euscaphis japonica.
AID464581Cytotoxicity against human SK-MEL-2 cells by SRB assay2010Bioorganic & medicinal chemistry letters, Mar-15, Volume: 20, Issue:6
Bioactivity-guided isolation of cytotoxic triterpenoids from the trunk of Berberis koreana.
AID1615643Ratio of MBC to MIC for Haemophilus influenzae type b ATCC 49247 by M7-A9 microdilution method2019Journal of natural products, 09-27, Volume: 82, Issue:9
Constituents from
AID426213Cytotoxicity against human SK-MEL cells upto 50 uM by neutral red assay2009Journal of natural products, Jun, Volume: 72, Issue:6
Scuteflorins A and B, dihydropyranocoumarins from Scutellaria lateriflora.
AID464580Cytotoxicity against human SKOV3 cells by SRB assay2010Bioorganic & medicinal chemistry letters, Mar-15, Volume: 20, Issue:6
Bioactivity-guided isolation of cytotoxic triterpenoids from the trunk of Berberis koreana.
AID464579Cytotoxicity against human A549 cells by SRB assay2010Bioorganic & medicinal chemistry letters, Mar-15, Volume: 20, Issue:6
Bioactivity-guided isolation of cytotoxic triterpenoids from the trunk of Berberis koreana.
AID1651606Cytoprotective activity against LPS-induced NRK-52E cells assessed as reduction in cell death measured every 5 min for 72 hrs by xCELLigence based RTCA analysis2020Journal of natural products, 04-24, Volume: 83, Issue:4
Renoprotective Mono- and Triterpenoids from the Fruit of
AID1871465Anti-platelet aggregation activity in human platelets assessed as inhibition of epinephrine induced aggregation
AID1436764Anticomplement activity in New Zealand White rabbit erythrocytes assessed as concentration required for 50% hemolytic inhibition by alternative pathway preincubated for 10 mins with normal human serum followed by erythrocyte addition measured after 30 min2017Bioorganic & medicinal chemistry letters, 02-15, Volume: 27, Issue:4
Anticomplement triterpenoids from the roots of Ilex asprella.
AID426215Cytotoxicity against human BT549 cells upto 50 uM by neutral red assay2009Journal of natural products, Jun, Volume: 72, Issue:6
Scuteflorins A and B, dihydropyranocoumarins from Scutellaria lateriflora.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (50)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (2.00)18.2507
2000's13 (26.00)29.6817
2010's30 (60.00)24.3611
2020's6 (12.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 24.51

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index24.51 (24.57)
Research Supply Index3.99 (2.92)
Research Growth Index5.17 (4.65)
Search Engine Demand Index26.67 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (24.51)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (3.77%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other51 (96.23%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]